Biotechnology Summit

Witnesses: S. Shak, Genentech; R. Bunning, Nat. Rehab. Hosp.; J. Breyer-Lewis, Diab. Nephrol.; Lance Armstrong, Winner, Ô99 Tour de France & Testicular Cancer Survivor, & his physician, L. Einhorn; A. Ullian, Task Force on Science, Health Care & the Econ.; A. Levinson, Genentech; H. Termeer, Genzyme Corp.; H. Verfaillie, Monsanto; L. Edelheit, GE Corp. R&D; C. Cassel, Mt. Sinai Med. Center; P. Lynch, Fidelity Mgt. & Res. Co.; M. Kathy Behrens, Nat. Venture Cap. Assoc.; E. Fritzky, Immunex Corp.; D. Carbone, Vanderbilt-Ingram Cancer Cntr.; J. Smith, Vanderbilt Univ. Med. Cntr.; C. Rausch, Biopure Corp.; R. Dollens, Guidant Corp.; G. Rathmann, ICOS Corp.; & A. Sager, Boston Univ.

The International Conference on Innovations in Biotechnology and Life Sciences (ICIBLS), 2020 was hosted by Delhi Technological University (formerly known as Delhi College of Engineering) virtually between 18th Dec - 20th Dec 2020. The three-day virtual conference witnessed a total of 1200 participants across different parts of the globe. The conference also provided a platform to 20 participants to present their innovative research work covering broad topics like Bioinformatics, Cancer Biology, Cell Biology, Disease Detection, Environmental Biotechnology, Food Technology, Immunology, Microbiology, Nanotechnology, Neuroscience, and Plant Biotechnology. In addition to this,13 national and international speakers and an industry-academia panel discussion enriched the conference with their knowledge and insights of the field. Thus, the conference provided a conducive environment that enabled accomplished scientists and research scholars to share their experiences and scientific knowledge related to novel and fundamental advances in the field of Biotechnology and Life Sciences. The present book is a compilation of the abstracts submitted to the conference on recent advances in the field of biotechnology and life sciences. The innovative ideas and studies of students and researchers from all over the globe are being compiled for upliftment and flourishing of science and research.

Breakthroughs in biotechnology are redefining the very concept of life, transforming society and presenting unprecedented opportunities and challenges: Will human genome sequencing help to treat genetic diseases and indefinitely prolong life? Will stem cell therapy and tissue engineering allow routine regeneration and replacement of diseased organs? Can new diagnostic tests revolutionize medicine and healthcare? Will genetic engineering allow parents to design perfect babies? Can nature’s workshop inspire superior biomaterials that transform industries? Will genetically modified super crops feed a hungry world? With biotechnology set to be the driving force of the twenty-first century, mastery of the life sciences will be the key to wealth generation and economic ascendancy. Can the Arab World regain its past supremacy in these fields? Can it benefit from the biotech revolution while avoiding its perils? Such implications were debated by experts at the ECSSR Eighth Annual Conference titled Biotechnology and the Future of Society: Challenges and Opportunities, held from January 11-13, 2003 in Abu Dhabi, United Arab Emirates. This volume of conference presentations explores the broad impact of the biotech revolution, highlighting trends in healthcare and molecular medicine, the genetic revolution in agriculture, the future of materials production, new drug discovery technologies and national security issues, including the threat of bio-terrorism. It also examines the complex ethical, legal and social issues raised by the biotech revolution that need to be resolved by governments and decision makers.